Introduction {#s1}
============

γδ T cells have been conserved since the emergence of jawed vertebrates \>450 million years ago alongside B cells and αβ T cells and play an important role in antimicrobial and antitumor immunity ([@bib28]; [@bib10]; [@bib75]). Like αβ T cells and B cells, γδ T cells use V(D)J (V, variable; D, diversity; J, joining) gene rearrangement with the potential to generate a set of highly diverse receptors to recognize antigens. This diversity is generated mainly in the complementarity-determining region 3 (CDR3) of the TCR formed by V(D)J gene rearrangements in the TRG and TRD loci. A high level of junctional diversity is caused by the random insertion of nucleotides (denoted by N) by the enzyme terminal deoxynucleotidyl transferase (TdT) into the junctions of the joining gene segments ([@bib9]). Mainly based on findings in the mouse model, γδ T cells are regarded as innate T cells. Indeed, waves of γδ T cell subsets are generated in the mouse thymus, especially before birth, that possess invariant TCRs (i.e., the same CDR3γ and CDR3δ sequences) and programmed effector functions, such as invariant Vγ5Vδ1 T cells that home to the skin epidermis as dendritic epidermal T cells ([@bib27]; [@bib33]; [@bib83]). After birth, a more diverse γδ TCR repertoire is generated, but thymic programming (IL17 versus IFNγ effector dichotomy) is still present ([@bib64]; [@bib57]). In contrast, human γδ thymocytes, at least postnatally, do not show such a functional commitment ([@bib65]). Further arguing against the generation of "innate" γδ T cells in the human thymus is the recent finding that the TRG and TRD repertoire of human pediatric thymuses and of term-delivery cord blood (CB) is highly polyclonal ([@bib62]; [@bib11]; [@bib36]; [@bib74]; [@bib15], [@bib16]). In adults, the γδ TCR repertoire in the peripheral blood becomes less diverse and highly focused, highlighting the potential adaptive function of human γδ T cells ([@bib62]; [@bib11]; [@bib74]). Thus, it is not clear whether thymic programming of γδ T cells exists in humans, further contributing to the notion that mouse and human γδ T cells are different ([@bib52]; [@bib58]; [@bib82]), possibly because human TCRs have an inherent bias to N-containing CDR3 regions ([@bib7]).

Immune cells are generated by hematopoietic stem and precursor cells (HSPCs). In the mouse model, evidence has been obtained for the developmentally ordered appearance (or "layered development") of distinct HSPCs that give rise to distinct immune cell lineages at different stages of development, including the generation of innate lymphocytes such as dendritic epidermal T cells and B1 lymphocytes ([@bib33]; [@bib27]; [@bib86]; [@bib22]; [@bib2]; [@bib61]; [@bib21]; [@bib44]; [@bib76]). However, other studies indicate that the available niche at the time of development is more important ([@bib81]). Whether a layered production of innate lymphocytes exists in humans is not known. Indeed, human fetal HSPCs are rather biased toward the generation of regulatory T cells, thus contributing to immune tolerance in the fetus ([@bib54]).

Here, we found that the human fetal thymus (FT) generates γδ T cells with invariant human CMV-reactive TCRs and programmed effector functions. Our data support the concept of a layered development as human fetal but not adult HSPCs could reproduce the generation of such innate γδ T cells. Finally, a key role for the RNA-binding protein Lin28b was demonstrated in the generation of human innate γδ T cells, both at the functional and TCR/CDR3 level.

Results {#s2}
=======

Human fetal γδ thymocytes express an effector program {#s3}
-----------------------------------------------------

Analyzing γδ thymocytes from pediatric thymuses (newborn to 9-yr-old children), [@bib65] did not find evidence (e.g., no IFNγ expression) for functional programming. Since functional programming of mouse γδ thymocytes is especially present at the time the first mouse T cells are generated (late gestation/perinatally), and since T cell development starts in humans well before birth ([@bib48]; [@bib83]), we investigated this issue in human FT samples. We sorted γδ (without the Vγ9Vδ2 subset; see Materials and methods) and αβ T cells from FT samples (17--19 wk gestation) and compared their gene expression profiles with their counterparts sorted from pediatric/postnatal thymuses (PNTs; 4 mo--8 yr). Comparing these gene expression profiles in an unbiased manner with a vast database of existing immune cell--associated gene sets (the Molecular Signatures Database \[MSigDB\] containing 4,872 immunological signatures; [@bib23]) revealed that FT γδ thymocytes share a gene expression program with activated T cells (both in human and mouse gene sets; [Fig. 1 A](#fig1){ref-type="fig"}). Furthermore, a high sharing with IL15-stimulated gene expression in natural killer (NK) cells was identified, again both in humans and mice ([Fig. 1 A](#fig1){ref-type="fig"}). Fetal γδ thymocytes clearly expressed IFNγ mRNA, while postnatal γδ thymocytes and fetal αβ thymocytes did not ([Fig. 1, B and C](#fig1){ref-type="fig"}). We confirmed the expression of IFNγ within ex vivo fetal γδ thymocytes at the protein level ([Fig. 1 D](#fig1){ref-type="fig"}), reaching similar levels as found in embryonic day 18 mouse thymocytes ([@bib57]), which was associated with their maturation status ([Fig. 1 E](#fig1){ref-type="fig"} and [Fig. S1 A](#figS1){ref-type="fig"}) and expression of the transcription factor Tbet ([Fig. S1 D](#figS1){ref-type="fig"}). Of note, while the level of maturation within fetal γδ thymocytes, despite the high variation, appeared to be higher compared with postnatal γδ thymocytes as assessed by the absence of CD1a expression, this probably does not reflect the relative absence of immature cells as this was not the case when assessed by the presence of CD27, a marker for mature thymocytes ([Fig. 1 C](#fig1){ref-type="fig"} and [Fig. S1, B and C](#figS1){ref-type="fig"}). More generally, fetal γδ but not αβ thymocytes were highly enriched for "cytokines" (analysis with Database for Annotation, Visualization, and Integrated Discovery \[DAVID\]: P = 0.00013 for functional annotation "cytokine"). Of note, in addition to TNF, a more general enrichment of members of the TNF superfamily was observed within fetal γδ thymocytes, including TRAIL (TNFSF10) and RANKL (TNFSF11; [@bib20]; [@bib66]; [Fig. 1 B](#fig1){ref-type="fig"} and Table S1). Among highly enriched genes were also the cytokine CSF1 (M-CSF; [@bib49]), the wound-healing associated cytokine amphiregulin ([@bib24]; [@bib45]), and the chemokines CCL4 and XCL1 (Table S1). At late gestation, mouse thymocytes (Vγ6^+^) are programmed to make IL17 ([@bib26]). We could not detect RNA transcripts of any of the IL17 members in human fetal γδ thymocytes. However, a range of genes described to have a role in IL17 production in γδ T cells were enriched within fetal γδ thymocytes: MAF, RORC (RORG), TGFBR3 and SMAD, IL23R and IL1R, BLK, and CCR6 ([@bib25]; [@bib19]; [@bib47]; [@bib89]; Table S1).

![**Fetalγδthymocytes express programmed effector functions. (A)** γδ thymocytes (without the Vγ9Vδ2 subset) were sorted from FT (*n* = 3) or PNT (*n* = 3) samples, and gene expression profiles were determined by RNAseq. GSEA plots based on the RNAseq dataset of FT versus PNT γδ thymocytes with the gene sets of activated (act.; versus naive) human ([GSE28726](GSE28726)) and mouse ([GSE10239](GSE10239)) T cells (top) and the gene sets of IL-15--stimulated (stim.; versus unstimulated) human ([GSE22886](GSE22886)) and mouse ([GSE7764](GSE7764)) NK cells (bottom). Gene sets are from the C7 immunological gene signature from the MSigDB. **(B)** Volcano plot illustrating differentially expressed genes between FT and PNT γδ thymocytes. **(C)** Heatmap of selected genes in FT and PNT γδ and αβ thymocytes. **(D)** Flow cytometry analysis of granzyme A (top) and IFNγ (bottom) expression by FT and PNT γδ and αβ thymocytes. Each symbol represents an individual donor: square symbols indicate CyToF data, and round symbols for γδ thymocytes indicate γδ thymocytes without the Vγ9Vδ2 subset. Horizontal lines indicate the median, and data were analyzed by Mann Whitney *U*test. \*, P \< 0.05; \*\*, P \< 0.01. **(E)** Flow cytometry plots of FT and PNT γδ thymocytes (without the Vγ9Vδ2 subset) illustrating the granzyme A^+^ cells within CD1a^−^ cells (top) and IFNγ^+^ cells within CD1a^−^ cells (bottom); data in the top and bottom panels are obtained from different subjects. The top panels are representative of five (FT) and six (PNT) independent experiments. The bottom panels are representative of one (FT) and seven (PNT) independent experiments. NES, normalized enrichment score.](JEM_20190580_Fig1){#fig1}

![**Flow cytometry data on FT and PNT thymocytes.(A)** Flow cytometry plots of FT and PNT γδ thymocytes illustrating the expression of granzyme A^+^ cells (left) and IFNγ^+^ cells (right) within mature CD27^+^ cells. **(B)** Flow cytometry plots illustrating the inverse relation of the expression of CD27 and CD1a maturation markers in FT and PNT γδ thymocytes. **(C)** Flow cytometry analysis of CD1a^−^ (left) and CD27^+^ (right) expression by fetal and postnatal γδ and αβ thymocytes. **(D)** Cytometry plot (based on CyToF data) of fetal γδ thymocytes illustrating IFNγ^+^ cells within Tbet^high^ cells. Representative of five (FT) and six (PNT) independent experiments (A, left; and B) or representative of one (FT) and seven (PNT) independent experiments (A, right). Horizontal lines indicate medians. Flow cytometry plots (A and B) and data (C) represent FT and PNT γδ thymocytes without the Vγ9Vδ2 subset.](JEM_20190580_FigS1){#figS1}

A striking observation was the high expression of cytotoxic granule-associated molecules within fetal γδ thymocytes, including several granzymes ([Fig. 1, B--D](#fig1){ref-type="fig"}). Protein expression of granzyme A was, like IFNγ, associated with maturation status ([Fig. 1 E](#fig1){ref-type="fig"} and [Fig. S1 A](#figS1){ref-type="fig"}). Furthermore, fetal γδ thymocytes expressed high levels of the transcription factor promyelocytic leukemia zinc finger (PLZF; also known as zinc finger and BTB domain containing 16 \[ZBTB16\]), a key "innate lymphocyte" regulator ([@bib70]; [@bib41]; [@bib43]; [Fig. 1, B and C](#fig1){ref-type="fig"}), and showed enriched expression for receptors of innate cytokines: IL1R1, IL1RL1 (ST2, the receptor for IL-33), IL18RAP/IL18R1, and IL23R ([Fig. 1 B](#fig1){ref-type="fig"} and Table S1).

In summary, fetal γδ thymocytes express high levels of the innate lymphocyte transcription factor PLZF and show an effector functional program (e.g., IFNγ and granzymes) and high expression of receptors for innate cytokines compatible with mature γδ T cells able to respond rapidly in the periphery after leaving the thymus.

Human fetal γδ thymocytes express invariant germline-encoded CDR3γ and CDR3δ {#s4}
----------------------------------------------------------------------------

Postnatal γδ thymocytes showed high expression levels of the TdT enzyme (also known as DNA nucleotidylexotransferase \[DNTT\]), while fetal γδ thymocytes expressed this enzyme only poorly ([Fig. 1 B](#fig1){ref-type="fig"}). Since TdT is essential for CDR3 variability by adding randomly N nucleotides during DNA recombination, we assessed the impact of this differential expression on the CDR3γ and CDR3δ repertoire. First, we performed flow cytometry with Vγ- and Vδ-specific antibodies and found that the FT showed a striking enrichment of the postnatally minor Vγ9^−^Vδ2^+^ subset ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib55]; [@bib84]; [@bib12]). Analysis at the mRNA level of V gene segment usage (TRGV and TRDV) in the CDR3γ and CDR3δ repertoire showed usage of all functional TRGV genes and of the nonfunctional ([@bib87]) TRGV10 gene segment and confirmed the increased usage of the TRDV2 gene segment within fetal γδ thymocytes, while TRDV1 was the main TRDV gene segment used in the postnatal γδ thymocytes ([Fig. 2 B](#fig2){ref-type="fig"}). Analyzing the CDR3 clonotypes revealed that postnatal thymocytes show a polyclonal repertoire ([Fig. 2, C and D](#fig2){ref-type="fig"}), as recently described ([@bib36]; [@bib16]). In contrast, however, fetal γδ thymocytes displayed an oligoclonal repertoire ([Fig. 2, C and D](#fig2){ref-type="fig"}), especially the CDR3γ. Indeed, the first 10 most abundant CDR3γ clonotypes accounted for about half of all the fetal γδ thymocyte CDR3γ repertoire ([Fig. 2 D](#fig2){ref-type="fig"}). Consistent with the low expression of the TdT enzyme in fetal γδ thymocytes ([Fig. 1 B](#fig1){ref-type="fig"} and [Fig. 2 E](#fig2){ref-type="fig"}), we found only a very low number of N insertions within the CDR3γ and CDR3δ ([Fig. 2 F](#fig2){ref-type="fig"} and [Fig. S2 A](#figS2){ref-type="fig"}). In contrast, the number of N insertions was high in postnatal thymocytes, with the CDR3δ showing a mean number of N insertions of 15, which was much higher than CDR3γ but also than CDR3α and CDR3β ([Fig. 2 F](#fig2){ref-type="fig"} and [Fig. S3 A](#figS3){ref-type="fig"}). The low level of N insertions in fetal γδ thymocytes resulted in an expected shorter CDR3δ length, which was also seen for CDR3α and CDR3β ([Fig. 2 G](#fig2){ref-type="fig"} and [Fig. S3 B](#figS3){ref-type="fig"}). Surprisingly, this was not the case for CDR3γ, which was likely due to a difference in TRGJ usage between fetal and postnatal γδ thymocytes: fetal γδ thymocytes were enriched for TRGJP1, which contains 4 nt more than TRGJ1, the most abundant TRGJ in postnatal thymocytes ([Fig. S2 C](#figS2){ref-type="fig"}), coinciding with the difference in N insertions ([Fig. 2 F](#fig2){ref-type="fig"}). This preferential TRGJP1 usage was most striking with TRGV8 and TRGV10 ([Fig. S2 D](#figS2){ref-type="fig"}), prevalent TRGV gene segments within fetal γδ thymocytes ([Fig. 2 B](#fig2){ref-type="fig"}). There was also a different TRDJ usage between fetal and postnatal thymocytes: a significant proportion of fetal γδ thymocyte CDR3δ used TRDJ2 and TRDJ3, while these TRDJs were only minimally present in postnatal thymocytes, where the vast majority used TRDJ1 ([Fig. S2 C](#figS2){ref-type="fig"}). This was observed with every TRDV ([Fig. S2 D](#figS2){ref-type="fig"}). Note that while the mean CDR3α and CDR3β lengths from αβ thymocytes were similar ([Fig. S3 B](#figS3){ref-type="fig"}), the CDR3γ length of γδ thymocytes was significantly smaller than the CDR3δ length ([Fig. 2 G](#fig2){ref-type="fig"}). Such a differential CDR3 length between the γ and δ chain has been described previously and is also found between the heavy and light chain of the B cell receptor/antibodies ([@bib68]; [@bib9]).

![**Human fetalγδthymocytes express invariant germline-encoded CDR3γand CDR3δ repertoires. (A)** Flow cytometry analysis of the expression of Vγ9^−^Vδ2^+^ γδ T cell subset in FT and PNT γδ thymocytes (left); representative flow cytometry plot of fetal γδ thymocytes (right). **(B)** HTS analysis of the V gene segment usage TRGV (left) and TRDV (right) in FT and PNT γδ thymocytes. TRG "Others" groups: TRGV1-TRGV3, TRGV5, TRGV5P, TRGV7, and TRGV11 variable chains; TRD "Others" groups: TRDV4, TRDV6, and TRDV7 variable chains. **(C)** Tree map representations of the CDR3γ and CDR3δ repertoires of FT and PNT γδ thymocytes (colors used are random; no correspondence between graphs). Representative of three independent experiments. **(D)** Accumulated frequencies (freq.) of the 10 most abundant clonotypes in CDR3γ and CDR3δ repertoires of γδ thymocytes in FT and PNT. **(E)** Analysis of the "counts per 20 million" (CP20M; RNAseq data) of the DNTT gene of γδ thymocytes in FT and PNT. **(F and G)** Mean number of N insertions (F) and CDR3 length (G; number of nucleotides) in CDR3γ and CDR3δ repertoires of γδ thymocytes in FT and PNT. **(H)** Overlap analysis showing the percentage of shared CDR3γ and CDR3δ clonotypes among three FT γδ thymocytes and among three PNT γδ thymocytes. **(I)** Percentage of particular clonotype amino acid sequences in CDR3γ and CDR3δ repertoires in FT and PNT γδ thymocytes. Each symbol (A, E--G, and I) represents an individual donor. Graphs show the means ± SEM (B, D, and H) or the mean (A, E--G, and I). Data were analyzed by Student's *t* test; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. *n* = 8 (FT) and 17 (PNT; A) or *n* = 3 (FT and PNT; B--I).](JEM_20190580_Fig2){#fig2}

![**TCR/CDR3 data of FT and PNTγδthymocytes. (A and B)** Number of N insertions (A) and CDR3 length (B; number of nucleotides) of CDR3 containing the indicated TRGV and TRDV, from sorted FT and PNT γδ thymocytes. **(C)** J and D gene segment usage in TRG and TRD of sorted FT and PNT γδ thymocytes. **(D)** J gene segment usage in TRGV2, TRGV3, TRGV4, TRGV5, TRGV8, TRGV10, TRDV1, TRDV2, TRDV3, TRDV5, and TRDV8 of sorted FT and PNT γδ thymocytes. *n* = 3 for FT and PNT nonVγ9Vδ2 sorted γδ thymocytes. Horizontal lines in A and B indicate means; means ± SEM are shown in C and D. Data were analyzed by Student's *t* test; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20190580_FigS2){#figS2}

![**CDR3 data onαβthymocytes. (A and B)** Number of N insertions (A) and CDR3 length (B; number of nucleotides) in CDR3α and CDR3β repertoires of αβ thymocytes derived from FTs and PNTs. Colors represent replicates from the same subject with 10,000 αβ thymocytes (circles \[FTs\] and squares \[PNTs\] with black border) or 100,000 αβ thymocytes (circles \[FTs\] and squares \[PNTs\]). Horizontal lines indicate medians. Data were analyzed by Mann Whitney test; \*\*, P \< 0.01.](JEM_20190580_FigS3){#figS3}

We found that the repertoire of fetal γδ thymocytes was highly shared, i.e., exactly the same clonotypes were used in fetal γδ thymocytes derived from different subjects ([Fig. 2 H](#fig2){ref-type="fig"}). Investigating this further, we detected a striking enrichment of particular clonotype sequences that were completely germline encoded (i.e., no N and P nucleotides): TRGV8-TRJP1 CATWDTTGWFKIF, TRVG10-TRJP1 CAAWDTTGWFKIF, TRDV2-TRDD3 CACDTGGY, and TRDV1-TRDD3 CALGELGD ([Fig. 2 I](#fig2){ref-type="fig"}).

In summary, fetal γδ thymocytes show clearly a distinct γδ TCR repertoire possessing CDR3 with low N insertions, coinciding with low TdT expression, resulting in a highly shared repertoire that is strikingly enriched for particular invariant CDR3 sequences.

The capacity to generate γδ T cells with programmed effector functions, low TdT expression, and invariant CDR3γ and CDR3δ is a property of fetal HSPCs {#s5}
------------------------------------------------------------------------------------------------------------------------------------------------------

The first wave of mouse γδ T thymocytes (possessing an invariant Vγ5Vδ1 TCR) can be generated in a fetal thymic organ culture system only when HSPCs of fetal origin, and not adult, are used ([@bib33]; [@bib27]). We wondered whether the unique properties of fetal γδ thymocytes described above (programmed function, invariant CDR3) could be due to differences in HSPCs present early versus later in life. To address this, we used the in vitro OP9DL1 co-cultures that are efficient in generating human γδ T cells starting with CD34^+^ HSPCs ([@bib79]). Thus, we generated γδ T cells in vitro starting with CD34^+^ HSPCs derived from several sources: fetal liver (FL; 15--21 wk gestation), fetal blood (FB; 24--31 wk gestation), CB (\>37 wk gestation), and mobilized adult blood (AB; \>18 yr).

Gene expression profiling and gene set enrichment analysis (GSEA) revealed that FL-derived γδ T cells clearly shared their gene expression profile with fetal γδ thymocytes, while AB-derived γδ T cells shared their gene expression profile with postnatal γδ thymocytes ([Fig. 3 A](#fig3){ref-type="fig"}). In line with this, FL-derived γδ T cells shared their gene expression profile with activated T cells and IL15-stimulated NK cells ([Fig. 3 B](#fig3){ref-type="fig"}). FL-derived γδ T cells, in contrast to AB-derived γδ T cells, were highly enriched for IFNγ, TNFα, secretory granule-associated molecules, CCL4, TGFBR3, PLZF (ZBTB16), and IL18RAP ([Fig. 3 C](#fig3){ref-type="fig"}). On the other hand, TdT (DNTT) showed high expression in AB-derived γδ T cells ([Fig. 3 C](#fig3){ref-type="fig"}). Thus FL-derived γδ T cells replicated the functional program observed in fetal γδ thymocytes.

![**Human fetal HSPC-derivedγδT cells share a functional transcriptional profile with fetalγδthymocytes.** γδ T cells were sorted from OP9DL1 cultures either derived from FL HSPCs (*n* = 3) or AB HSPCs (*n* = 3), and gene expression profiles were determined by RNAseq. **(A)** GSEA plots quantifying the shared profile of FL-derived and AB-derived γδ T cells with FT and PNT thymocytes, respectively. **(B)** GSEA plots quantifying the shared profile of FL-derived and AB-derived γδ T cells with activated (act.; versus naive) human ([GSE28726](GSE28726)) and mouse ([GSE10239](GSE10239)) T cells (top) and with IL-15--stimulated (stim.; versus unstimulated) human ([GSE22886](GSE22886)) and mouse ([GSE7764](GSE7764)) NK cells (bottom). Gene sets are from the C7 immunological gene signature from the MSigDB. **(C)** Volcano plot illustrating differentially expressed genes between FL- and AB-derived γδ T cells. NES, normalized enrichment score.](JEM_20190580_Fig3){#fig3}

Analysis of the Vδ and Vγ expression on the cell surface by flow cytometry revealed that fetal HSPCs (FL and FB) are very efficient in the generation of Vδ2^+^ cells ([Fig. 4, A--C](#fig4){ref-type="fig"}), which was confirmed by V gene segment usage analysis by high-throughput sequencing (HTS; [Fig. 4 D](#fig4){ref-type="fig"}). Thus, as observed in ex vivo fetal versus postnatal γδ thymocytes ([Fig. 1 B](#fig1){ref-type="fig"} and [Fig. 2 B](#fig2){ref-type="fig"}), FL/FB-derived γδ T cells and CB/AB-derived γδ T cells were enriched for TRDV2 and TRDV1, respectively ([Fig. 3 C](#fig3){ref-type="fig"} and [Fig. 4 D](#fig4){ref-type="fig"}). The CDR3γ and CDR3δ repertoires in fetal HSPC OP9DL1 cultures were more oligoclonal than the repertoires derived from OP9DL1 cultures with HSPC sources of later life (CB and AB; [Fig. 5, A and B](#fig5){ref-type="fig"}) and expressed low TdT levels ([Fig. 5 C](#fig5){ref-type="fig"}), resulting in a low number of N insertions ([Fig. 5 D](#fig5){ref-type="fig"}), again as observed ex vivo in fetal versus postnatal γδ thymocytes ([Fig. 2, C--F](#fig2){ref-type="fig"}). In comparison to the CDR3 repertoire of CB/AB-derived γδ T cells, the CDR3 repertoire of FL/FB-derived γδ T cells was highly shared and also showed high sharing with the ex vivo fetal γδ thymocytes ([Fig. 5 E](#fig5){ref-type="fig"}). Strikingly, FL/FB-derived, but not CB/AB-derived, γδ T cells were efficient in the generation of the invariant germline-encoded CDR3 sequences TRGV8-TRJP1 CATWDTTGWFKIF, TRDV2-TRDD3 CACDTGGY, and TRDV1-TRDD3 CALGELGD ([Fig. 5 F](#fig5){ref-type="fig"}), which are also enriched in fetal γδ thymocytes ex vivo ([Fig. 2 I](#fig2){ref-type="fig"}).

![**Human fetal HSPCs efficiently generate V**γ**9^−^Vδ2^+^γδT cells.** **(A)** Kinetics of the percentage of γδ T cells (of CD7^+^ cells), Vδ2^+^, and Vδ1^+^ γδ T cells (top) and of the absolute number (bottom) analyzed by flow cytometry and derived from FL, FB, CB, and AB HSPCs during co-culture with OP9DL1 cells. For each time point, *n* ranges from 2 to 3 (FL), 6 to 9 (FB), 7 to 11 (CB), and 3 to 4 (AB). **(B)** Ratio between Vδ2^+^ versus Vδ1^+^ γδ T cells at day 30 ± 2 of OP9DL1 co-culture (*n* = 3, 9, 11, and 4, respectively, for FL-, FB-, CB-, and AB-derived HSPCs). **(C)** Flow cytometry analysis of the expression of Vδ2 and Vδ1 chains of γδ T cells derived from FB HSPCs and of the expression of the Vδ9 chain on the Vδ2^+^ γδ T cells at day 30 ± 2. Numbers indicate the percentage of the corresponding population. Data are representative of 11 independent experiments. On the right, percentage of the Vγ9-Vδ2^+^ γδ T cell subset (gated on Vδ2^+^ γδ T cells) from FL, FB, CB, and AB HSPCs at day 30 ± 2 of OP9-DL1 co-culture (*n* = 3, 9, 11, and 4, respectively, for FL, FB, CB, and AB). **(D)** HTS analysis of the V gene segment usage TRGV (left) and TRDV (right) of sorted γδ T cells derived from FL (*n* = 3), FB (*n* = 4), CB (*n* = 6), and AB (*n* = 3) HSPCs. TRG "Others" groups: TRGV1-TRGV3, TRGV5, TRGV5P, TRGV7, and TRGV11 variable chains; TRD "Others" groups: TRDV4, TRDV6, and TRDV7 variable chains. Graphs show the means ± SEM (A and D) or the medians ± range (B and C). Data were analyzed by Kruskal-Wallis ANOVA followed by Dunn's multiple comparison test; \*, P \< 0.05; \*\*, P \< 0.01.](JEM_20190580_Fig4){#fig4}

![**Human fetal HSPCs efficiently generate invariant CDR3γand CDR3δ sequences. (A)** Tree map representations of the CDR3γ and CDR3δ repertoires of OPDL1 cultures derived from FL, FB, CB, and AB HSPCs (colors in the tree maps are random; no correspondence between graphs). Graphs are representative of 3 (FL), 8 (FB), 10 (CB CDR3γ), 9 (CB CDR3δ), and 4 (AB) independent experiments. **(B)** Accumulated frequencies (freq.) of the 10 most abundant clonotypes of the CDR3γ and CDR3δ repertoire derived from total cells. FL (*n* = 3), FB (*n* = 8), CB (*n* = 10 for CDR3γ and 9 for CDR3δ), and AB (*n* = 4). **(C)** CP20M of the RNAseq data of DNTT (TdT) of γδ T cells derived from FL and AB HSPCs. **(D)** Mean number of N insertions in CDR3γ and CDR3δ repertoires of total cells, sorted γδ T cells, and sorted progenitor cells derived from FL, FB, CB, and AB HSPCs after co-culture with OP9DL1 cells. **(E)** Overlap analysis showing the percentage of shared CDR3γ and CDR3δ clonotypes among three FL, four FB, six CB, and three AB sorted γδ T cells derived from HSPCs and among these groups with three FT and three PNT thymus nonVγ9Vδ2 sorted γδ thymocytes. **(F)** Percentage of particular CDR3 clonotype amino acid sequences present in total cells, sorted γδ T cells, and sorted progenitor cells derived from FL, FB, CB, and AB HSPCs. Each symbol (C, D, and F) represents an individual donor. Graphs show the means ± SEM (B and E). Data were analyzed by Student's *t* test (C) and Kruskal-Wallis ANOVA followed by Dunn's multiple comparison test (D and F); \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20190580_Fig5){#fig5}

In summary, fetal HSPC-derived γδ T cells (using the in vitro T cell development system OP9DL1) share with ex vivo fetal γδ thymoctyes: (i) a functional effector program; (ii) low TdT expression; and (iii) invariant germline-encoded CDR3 sequences, indicating that stem cell-autonomous mechanisms are underlying the generation of the programmed and invariant human γδ thymocytes.

The invariant germline-encoded CDR3γ and CDR3δ are generated independently of functional TCR expression {#s6}
-------------------------------------------------------------------------------------------------------

We wondered whether a selection mechanism is involved in the observed invariant sequences that are prevalent in fetal γδ thymocytes and dependent on fetal HSPCs. We therefore analyzed the preselection γδ TCR repertoire of (i) sorted CD3neg T cell progenitors from the OP9DL1 cultures and (ii) TRGV10-containing CDR3 sequences, which cannot express a TCR at the cell membrane. Indeed, TRGV10 is expressed at the RNA level but cannot be further translated because of the absence of splicing of the leader intron that leads to the generation of a stop codon ([@bib87]; and confirmed by the analysis of our HTS data: [Fig. S4](#figS4){ref-type="fig"}). By comparing the CDR3 repertoire of sorted γδ T cells from OP9DL1 cultures with that of sorted progenitors, we found that already at the progenitor level, the rearranged CDR3 sequences of FL and FB HSPC cultures show low N insertions and are highly enriched for the invariant germline-encode CDR3 sequences TRGV8-TRGJP1 CATWDTTGWFKIF, TRDV2-TRDD3 CACDTGGY, and TRDV1-TRDD3 CALGELGD ([Fig. 5, D and F](#fig5){ref-type="fig"}). Our HTS strategy based on template-switch cDNA generation allowed us to generate CDR3 sequences containing the nonfunctional VγIII member TRGV10 ([@bib87]; in contrast to using specific primers against the VγI \[members TRGV2, 3, 4, 5, and 8\] and VγII \[member TRGV9\]; [@bib62]; [@bib11], [@bib12]). We found that TRGV10-containing CDR3 sequences were strikingly enriched for the TRGV10-TRGJP1 CAAWDTTGWFKIF sequence both in ex vivo fetal γδ thymocytes ([Fig. 2 I](#fig2){ref-type="fig"}) and FL/FB-derived γδ T cells ([Fig. 5 F](#fig5){ref-type="fig"}). As expected, this TRGV10-associated sequence was also already enriched at the progenitor level of FL/FB OP9DL1 cultures ([Fig. 5 F](#fig5){ref-type="fig"}). Thus, we conclude that the high frequency of invariant germline-encoded sequences is not caused by a selection of these sequences among many other rearranged CDR3 sequences but is intrinsically determined at the level of the HSPC/γδ progenitor.

![**TRDV10 RNA contains the leader intron introducing a stop codon.** Shown are the R1 and R2 raw data reads of a TRGV10-containing sequence that possesses the invariant germline-encoded CDR3 CAAWDTTGWFKIF.](JEM_20190580_FigS4){#figS4}

The V, J, and D gene segments composing the invariant germline-encoded CDR3γ and CDR3δ contain short homology repeats {#s7}
---------------------------------------------------------------------------------------------------------------------

As the high enrichment of invariant CDR3γ and CDR3δ within the FT and within fetal HSPC-derived γδ T cells appears not to be due to a selection process involving the TCR, we investigated alternative mechanisms. While the low expression of TdT ([Fig. 2 E](#fig2){ref-type="fig"} and [Fig. 5 C](#fig5){ref-type="fig"}) certainly contributes to a lower diversity within the CDR3, there are still a variety of recombinations possible involving different V and/or (D)J regions, with different degrees of removal of nucleotides at their ends before joining. This variation can be further increased by the addition of P nucleotides. Thus, despite this variation potential, particular sequences or motifs showed a striking enrichment ([Fig. 2 I](#fig2){ref-type="fig"} and [Fig. 5 F](#fig5){ref-type="fig"}). Inspired by previous work in the mouse model ([@bib34]; [@bib1]; [@bib88]), we discovered the presence of short homology repeats located at the 3′ end of the TRGV8/TRDV1/TRDV2 sequences and 5′ end of the TRGJP1/TRDD3 sequences ([Fig. 6 A](#fig6){ref-type="fig"}). These short homology repeats likely contribute to the enrichment of the observed invariant CDR3 sequences ([Fig. 6, B and C](#fig6){ref-type="fig"}). Such a motif was even observed for TRGV10 (to recombine with TRGJP1), which cannot generate a functional Vγ chain ([@bib87]; [Fig. 6 A](#fig6){ref-type="fig"}). Note that a 1-nt difference between TRDV1 and TRDV2 of the location of the short homology repeat resulted in a completely different invariant CDR3 sequence because of a different open-reading frame usage of the TRDD3 gene segment ([Fig. 6 C](#fig6){ref-type="fig"}). Thus, it appears that the absence of N nucleotides allows the recombination based on short homology repeats, thus generating the invariant germline-encoded sequences in fetal γδ thymocytes and FL/FB-derived γδ T cells: TRGV8-TRGJP1 CATWDTTGWFKIF, TRGV10-TRGJP1 CAAWDTTGWFKIF, TRDV2-TRDD3 CACDTGGY, and TRDV1-TRDD3 CALGELGD.

![**Short homology repeats at the VDJ junctions. (A)** Left, table showing the nucleotide sequences of the variable gene segments TRGV8 and TRGV10 (3′ ends, CDR3) and of the five joining gene segments TRGJ (J1/J2, JP, JP1, and JP2; 5′ ends, CDR3). Right, table showing the nucleotide sequences of the variable gene segments TRDV1 and TRDV2 and of the three diversity gene segments TRDD (D1, D2, D3). Short homology repeats are shown in red or in red and underlined. **(B)** Recombination using short homology repeats between TRGV8 and TRGJP1. Overlapping nucleotides are shown in red. **(C)** Recombination using short homology repeats between TRDV1 and TRDD3 and between TRDV2 and TRDD3. Overlapping nucleotides are shown in red (TRDV1-TRDD3) and in underlined red (TRDV2-TRDD3).](JEM_20190580_Fig6){#fig6}

Lin28b induces an effector program, inhibits TdT expression, and enhances the formation of germline-encoded invariant CDR3γ and CDR3δ sequences {#s8}
-----------------------------------------------------------------------------------------------------------------------------------------------

Both in ex vivo fetal γδ thymocytes (versus postnatal γδ thymocytes; [Fig. 1 B](#fig1){ref-type="fig"}) and in FL HSPC-derived γδ T cells (versus AB HSPC-derived γδ T cells; [Fig. 3 C](#fig3){ref-type="fig"}), the expression of the RNA-binding protein Lin28b was highly enriched, and MIRLET7B was highly depleted. Lin28b can block the bioprocessing of let-7 family microRNAs (miRNAs; [@bib35]; [@bib69]), providing an explanation of why the MIRLET7B host gene (MIRLET7HG) transcript is highly enriched within postnatal γδ thymocytes and AB-derived γδ T cells ([Fig. 1 B](#fig1){ref-type="fig"} and [Fig. 3 C](#fig3){ref-type="fig"}). As this RNA-binding protein has been described to be involved in murine innate-like lymphopoiesis ([@bib86]; [@bib35]), we wondered whether Lin28b is involved in the programmed effector functions, low TdT expression, and/or invariant CDR3 sequences that we observed in fetal γδ thymocytes and FL-derived γδ T cells. To test this hypothesis, we transduced CB HSPCs to express the human *LIN28B* gene and compared the γδ T cells derived from the *LIN28B* versus control OP9DL1 cultures. Lin28b overexpression resulted in a shared gene expression profile with FL-derived γδ T cells ([Fig. 7 A](#fig7){ref-type="fig"}), and in line with this, with activated T cells and IL15-stimulated NK cells ([Fig. 7 B](#fig7){ref-type="fig"}), as illustrated by an increase in the expression of effector molecules and the increased expression of PLZF (ZBTB16) and IGF2BP1 (another RNA-binding protein; [Fig. S5 A](#figS5){ref-type="fig"}). This was associated at the TCR/CDR3 level with a higher TRDV2/TRDV1 ratio ([Fig. 7 C](#fig7){ref-type="fig"}), increased oligoclonality ([Fig. S5 B](#figS5){ref-type="fig"}), a striking inhibition of TdT expression ([Fig. 7 D](#fig7){ref-type="fig"}) resulting in decreased N insertions ([Fig. 7 E](#fig7){ref-type="fig"}), and increased sharing ([Fig. 7 F](#fig7){ref-type="fig"}). Importantly, the overexpression of Lin28b led as well to an increased sharing of the CDR3 repertoire with FL/FB-derived γδ T cells ([Fig. 7 F](#fig7){ref-type="fig"}) and to increased levels of the germline-encoded invariant sequences ([Fig. 7 G](#fig7){ref-type="fig"} and [Fig. S5 C](#figS5){ref-type="fig"}). Note that, as before, the decreased level of N insertions and increased level of invariant CDR3 sequences was already observed at the progenitor level ([Fig. 7 E and G](#fig7){ref-type="fig"}; and [Fig. S5 C](#figS5){ref-type="fig"}).

![**Lin28b induces an effector program, inhibits TdT expression, and enhances the formation of germline-encoded invariant CDR3γand CDR3δ sequences. (A)** γδ T cells were sorted from OP9DL1 cultures either derived from Lin28b-transduced CB HSPCs (Lin28b; *n* = 3) or control-transduced CB HSPCs (Con.; *n* = 3). GSEA plots based on RNAseq data quantifying the shared profiles of Lin28b-derived versus control-derived γδ T cells with FL and AB HSPC-derived γδ T cells as gene sets. **(B)** GSEA plots quantifying the shared profile of Lin28b- versus control-transduced CB HSPC-derived γδ T cells with activated (act.; versus naive) human ([GSE28726](GSE28726)) and mouse ([GSE10239](GSE10239)) T cells (top) and with IL-15--stimulated (stim.; versus unstimulated) human ([GSE22886](GSE22886)) and mouse ([GSE7764](GSE7764)) NK cells (bottom). Gene sets are from the C7 immunological gene signature from the MSigDB. NES, normalized enrichment score. **(C)** Top, ratio between Vδ2^+^ and Vδ1^+^ γδ T cells derived from Lin28b-transduced CB HSPCs (Lin28b) and from control-transduced CB HSPCs (control) at day 30 ± 2 of OP9DL1 co-culture as determined by flow cytometry (*n* = 9 for Lin28b and control). Bottom, HTS analysis of the TRDV usage on sorted γδ T cells from Lin28b- and control-transduced CB HSPCs. "Others" groups: TRDV4, TRDV6, and TRDV7 variable chains (*n* = 5). **(D)** Paired comparison analysis of the CP20M RNAseq data of DNTT (TdT) expressed in γδ T cells derived from Lin28b- versus control-transduced CB HSPCs. **(E)** Mean number of N insertions in CDR3γ and CDR3δ repertoires of total cells, sorted γδ T cells, and sorted progenitor cells derived from Lin28b- versus control-transduced CB HSPCs. **(F)** Overlap analysis showing the percentage of shared CDR3γ and CDR3δ clonotypes among sorted γδ T cells (*n* = 6) derived from Lin28b- versus control-transduced CB HSPCs and among these samples with three FL, four FB, six CB, and three AB sorted γδ T cells derived from HSPCs. **(G)** Percentage of particular CDR3 clonotype amino acid sequences present in total cells, sorted γδ T cells, and sorted progenitor cells derived from Lin28b- versus control-transduced CB HSPCs. Lines between symbols link samples from the same subject (D, E, and G). Data are means ± SEM (C and F). Data were analyzed by paired Student's *t* test; \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.](JEM_20190580_Fig7){#fig7}

![**TCR/CDR3 and RNAseq data of Lin28b- versus control-transduced CB HSPC-derivedγδT cells. (A)** Paired comparison analysis of the CP20M (RNAseq data) for a selection of genes expressed in γδ T cells derived from Lin28b- versus control-transduced CB HSPCs. **(B)** Tree map representations (colors used are random; no correspondence between graph; top) and accumulated frequencies (freq.; bottom) of the 10 most abundant clonotypes of the CDR3γ and CDR3δ repertoires of total cells derived from OP9DL1 culture. Tree maps are representative of seven (Lin28b and control) independent experiments. Graphs show the means ± SEM. **(C)** Percentage of particular CDR3δ clonotype amino acid sequences present in total cells, sorted γδ T cells, and sorted progenitor cells derived from Lin28b- versus control-transduced CB HSPCs. *n* = 7 (for total) and *n* = 5 (for sorted γδ T cells and progenitors). Lines between symbols link samples from the same subject. Data were analyzed by paired Student's *t* test; \*, P \< 0.05; \*\*\*, P \< 0.001.](JEM_20190580_FigS5){#figS5}

We conclude that the RNA-binding protein Lin28b is a major determinant in the HSPC-dependent generation of human fetal invariant and programmed effector γδ thymocytes.

Discussion {#s9}
==========

In this study we provide a detailed description of the differences between human fetal and postnatal γδ thymocytes with regard to programmed effector function and invariant CDR3 sequences. Furthermore, we demonstrated that these differences are HSPC-dependent and are mediated to a major extent by the RNA-binding protein Lin28b.

Human fetal γδ thymocytes shared gene expression profiles with activated T cells and IL15-stimulated NK cells. Of note, IL15 has been found to play an important role in the development of innate γδ T cells (Vγ5Vδ1) in the mouse FT ([@bib13]). Human fetal γδ thymocytes expressed high levels of the innate lymphocyte transcription factor PLZF and showed an effector functional program (e.g., IFNγ and granzymes) and high expression of receptors for innate cytokines. Furthermore, we found that this thymic programming is determined at the level of fetal HSPCs. This is in marked contrast with the described bias of human fetal peripheral αβ T cells toward the regulatory T cell lineage to suppress fetal antimaternal immunity ([@bib53], [@bib54]). However, the fetus also needs to be protected against congenital infections and exposure to pathogens at birth ([@bib40]). The γδ functional effector profile programmed within the FT may contribute efficiently to such protection. We have shown previously that upon congenital CMV infection, γδ T cells are expanded in the periphery and express high levels of IFNγ and granzymes ([@bib84]). We here show that this functional program may be established within the FT. Alternatively, such a programmed functional program could serve "nonimmunological" functions in early life, such as body temperature regulation at birth and brain development ([@bib39]; [@bib63]).

Fetal and postnatal γδ thymocytes clearly differed in their TCR repertoire. While some differences have been described previously (such as the preferred TRDV2 usage in the FT; [@bib51]; [@bib42]), a main finding in this study was the identification via HTS of highly enriched germline-encoded invariant CDR3 sequences within fetal γδ thymocytes (TRGV8-TRGJP1 CATWDTTGWFKIF, TRGV10-TRGJP1 CAAWDTTGWFKIF, TRDV2-TRDD3 CACDTGGY, and TRDV1-TRDD3 CALGELGD). While the low TdT expression can contribute to a lower CDR3 variability, it cannot explain the prevalence of these particular sequences. Furthermore, our data regarding the nonfunctional ([@bib87]) TRGV10-TRJP1 CDR3 sequence and CDR3 data derived from T cell progenitors strongly indicate that the high prevalence of these sequences does not depend on a γδ TCR-dependent signal. We rather propose that the presence of short homology repeats at the end of the involved V, D, and J gene segments can dictate the recombination sites. Such short homology repeats have been identified previously in "early" mouse invariant CDR3 sequences ([@bib34]; [@bib88]). Importantly, it has been demonstrated (using recombination substrates in a transgenic mouse model) that such repeats have strong effects on the recombination site and that this process is inhibited by the overexpression of TdT ([@bib88]). Thus, while human and mouse γδ TCR sequences and γδ T cell subsets are usually regarded as highly different, it appears that the mechanism to generate germline-encoded invariant sequences is conserved. Furthermore, it seems that for some recombination events the same short homology repeats are used: "(a)ta" is present at the 3′ end of the human TRGV8/TRGV10 and mouse TRGV5/TRGV6, while "ata" is present at the 5′ end of the human TRGJP1 and mouse TRGJ1 ([@bib34]). This evolutionary conservation at the level of the generation of the innate γδ mouse and human TCRs parallels the evolutionary conservation of selective γδ T cell responses to butyrophilins and butyrophilin-like proteins ([@bib4]; [@bib17]; [@bib29]). The nonfunctional TRGV10-TRGJP1 CAAWDTTGWFKIF CDR3 sequence is very similar to the functional TRGV8-TRJP1 CATWDTTGWFKIF CDR3 sequence, only different in the third amino acid that is encoded by the TRGV gene segment. Of note, while TRGV10 is not functional in humans, the orthologues in other primates studied are functional ([@bib38]). We have found previously a striking enrichment of an invariant Vγ8Vδ1 CMV-reactive TCR in the blood of fetuses and newborns with congenital CMV infection ([@bib84]; [@bib71]). The CDR3γ of this Vγ8Vδ1 TCR is exactly the same as the one that was found here to be highly enriched in the FT, while the CDR3δ CALGELGD sequence (the part formed by short homology recombination between TRDV1 and TRDD3) present in the CMV-expanded clones was also found here to be highly enriched among FT TRDV1-containing sequences. Furthermore, the FT-enriched TRDV2-TRDD3 CACDTGGY sequence has also been found to be enriched upon congenital CMV infection ([@bib84]). Thus, the short homology repeats contained in the V, D, and J segments forming these germline-encoded invariant sequences may have been evolutionarily selected to ensure antiviral fetal γδ T cells in utero. We propose that these invariant γδ T cells home to peripheral tissues after exiting the thymus and highly expand upon (CMV) infection, explaining their presence within the blood of CMV-infected newborns ([@bib84]). Such an innate establishment of a tissue-associated γδ TCR repertoire from which adaptive expansions can occur has been recently coined "adaptate" biology ([@bib29]).

We show here for the first time that Lin28b has a profound influence on the γδ TCR repertoire as well as on the programming of effector functions in γδ thymocytes. The highly conserved RNA-binding protein Lin28b is involved in many biological processes (including development, reprogramming, pluripotency, and metabolism) and can function as an oncogene ([@bib56]; [@bib35]; [@bib30]). Lin28b was highly expressed in ex vivo--derived fetal γδ thymocytes and in in vitro fetal HSPC-derived γδ T cells, while the TdT enzyme was poorly expressed. Overexpression of Lin28b resulted in a striking down-regulation of TdT, which was accompanied by an increased generation in the invariant CDR3 sequences. Thus, it appears that the low TdT expression in fetal γδ thymocytes is the result of an active suppression mechanism mediated by Lin28b. Lin28b can mediate its effects via two main mechanisms: via the down-regulation of members of the let7 miRNA family (that can effect degradation and/or translation of their mRNA targets) or via selectively binding mRNAs to promote their translation ([@bib35]). Our data indicate that the let7 pathway is involved, since effects were seen at the mRNA level upon Lin28b overexpression, and MIRLET7BHG was highly enriched in PNTs and AB HSPC-derived γδ T cells. We propose that the active inhibition of TdT expression in developing γδ thymocytes results in no (or very low level of) N nucleotide insertions, allowing the recombination of the short homology repeats to occur, leading to the described generation of invariant TCR sequences. In later life, Lin28b expression is decreased and TdT increased, resulting in the incorporation of N nucleotides, preventing this short homology--mediated recombination. In addition, it is likely that Lin28b also affects the γδ TCR repertoire independently of TdT inhibition, since Lin28b overexpression altered the Vδ gene segment usage (increased Vδ2/Vδ1 ratio).

The effector program (e.g., IFNγ and granzymes) observed in ex vivo fetal γδ thymocytes was HSPC- and Lin28b-dependent. Since these effector molecules do not contain a let7 motif within the 3′ untranslated region of their mRNA sequences (where typically miRNA-binding sites are found; [@bib85]), it is more likely that the Lin28b/let7-dependency is indirect. One possibility is via the innate lymphocyte transcription factor PLZF (ZBTB16), which was highly expressed by ex vivo fetal γδ thymocytes and fetal HSCP-derived γδ T cells and showed increased expression upon Lin28b overexpression. Indeed, PLZF has been shown to be a target of let7 miRNA ([@bib60]) and to promote the development of mouse innate γδ T cells ([@bib43]). Also, the RNA-binding protein IGFBP1 (highly prevalent in ex vivo fetal γδ thymocytes and fetal HSPC-derived γδ T cells and increased upon Lin28b expression) is a let7 target ([@bib5]). Interestingly, IGFBP1 has been recently shown to be involved in the generation of human fetal hemoglobin in fetal HSPC-derived erythroblasts ([@bib14]). Finally, in contrast to our observations in γδ T cells, Lin28b promotes the generation of regulatory T cells in human peripheral fetal αβ T cells ([@bib6]), thus highlighting a differential effect of the same RNA-binding protein in the γδ versus αβ T cell lineage. More generally, our study identifies evolutionarily conserved mechanisms in the ontogeny of γδ T cells in humans, and the insights provided can contribute to a better understanding of the immune response toward infectious diseases occurring during fetal life versus adult life ([@bib40]; [@bib37]).

Materials and methods {#s10}
=====================

Human cell material {#s11}
-------------------

FT (*n* = 8) and FL (*n* = 3) samples (15--21 wk gestation) were obtained with approval of the Centralized Institutional Research Board of the Singapore Health Services in Singapore. PNT (*n* = 17; 4 mo--9 yr) samples and mobilized peripheral blood samples of adult donors (*n* = 4; \>18 yr) were obtained with approval of the Medical Ethical Commission of the Ghent University Hospital (Belgium). FB (*n* = 11; 24--31 wk gestation) samples from interruption of pregnancy were obtained with approval of the Erasme Hospital (Université Libre de Bruxelles) Ethics Committee, and umbilical CB (*n* = 16; \>37 wk gestation) samples after delivery were obtained with approval of the University Hospital Center Saint-Pierre (Belgium). For all the samples used in this work, written informed consent was given.

Isolation of cells {#s12}
------------------

Cell suspension from FT and PNT samples was obtained as previously described ([@bib50]; [@bib79]). γδ T cells from postnatal suspensions were isolated by positive selection using anti-TCRγδ magnetic activated cell sorting beads (Miltenyi Biotec) according to the manufacturer's instruction. Note that since it appears that the phosphoantigen-reactive Vγ9Vδ2 subset follows different rules compared with all the other human γδ T cell subsets regarding the CDR3 repertoire, we excluded the Vγ9Vδ2 subset. Indeed, in contrast to other subsets (such as Vδ1^+^ and Vγ9^−^Vδ2^+^), Vγ9Vδ2 T cells express a semi-invariant TCR in AB and CB ([@bib11], [@bib12]; [@bib18]; [@bib59]; [@bib62]; [@bib72]). Thus, the γδ^+^ fraction was further sorted into CD3^+^TCRγδ^+^ without the Vγ9^+^Vδ2^+^ subset (nonVγ9Vδ2 γδ T cells), while from the γδ-negative fraction, αβ T cells (CD3^+^ TCRγδ^−^) were sorted (all around 10,000 cells, except when indicated) on a FACS Aria III cell sorter (BD Biosciences), snap-frozen in liquid nitrogen, and stored at −80°C for later RNA extraction. The mean purity was 95.0% (percentage of living cells).

Mononuclear cells were collected from blood samples (FB, CB, and AB) by Lymphoprep gradient centrifugation (Axis-Shield). Cell suspensions from FL samples were obtained as previously described ([@bib50]). CD34^+^ HSPCs were isolated by anti-CD34 magnetic activated cell sorting beads (Miltenyi Biotec) by positive selection according to the manufacturer's instruction. Purity was 92.0%, and the percentage of CD3^+^TCRγδ^+^ cells was \<0.6 (percentage of living cells).

OP9DL1 co-cultures {#s13}
------------------

OP9DL1 cells were obtained from Dr. J.C. Zuniga Pflucker (University of Toronto, Toronto, Canada; [@bib46]). Isolated CD34^+^ cells were seeded in a 6-well culture plate (5 × 10^5^ cells/well) containing a monolayer of OP9DL1 cells in MEMα (Gibco BRL Life Technologies) supplemented with 20% FBS (Sigma-Aldrich), 1% nonessential amino acids, 1% glutamine, and 1% penicillin/streptomycin (Pen/Strep; Lonza) in the presence of 10 ng/ml IL-7 (R&D Systems), 10 ng/ml Flt3L (PeproTech), and 5 ng/ml stem cell factor (SCF; PeproTech). Every 4--5 d cells were harvested by vigorous pipetting and transferred in a new 6-well plate (5 × 10^5^--5 × 10^6^ cells/well; [@bib79]). Differentiation of HSPCs was analyzed by flow cytometry, characterized by the gradual loss of the HSPC marker CD34 and parallel increase of the T progenitor marker CD7 ([@bib79]; [@bib46]). After 2 or 4 wk in co-culture, \>96% of living cells were CD7^+^. The CD1a marker was used to assess the maturation state. After ∼30 d in co-culture with OP9DL1 cells ([Fig. 4 A](#fig4){ref-type="fig"}), HPSC-derived cells were stained, and CD3^+^TCRγδ^+^ (defined as γδ T cells) and CD3^−^TCRγδ^−^ (defined as progenitors) cell populations were sorted (2,000--30,000 γδ cells, 100,000--150,000 precursor cells) on a FACS Aria III cell sorter, snap-frozen in liquid nitrogen, and stored at −80°C for later RNA extraction. Purity was \>98% (percentage of living cells).

Retroviral vectors, transfection, and transduction {#s14}
--------------------------------------------------

Human *LIN28B* ([NM_001004317](NM_001004317)) was amplified via PCR from MSCV-Lin28b-PIG (gift from the laboratory of Joshua Mendell, University of Texas Southwestern Medical Center, Dallas, TX) introducing BamHI restriction enzyme sites ([@bib30]). The amplified PCR product was cloned into the BamHI site of the retroviral LZRS-ires-eGFP plasmid, and retroviral particles were produced as previously described ([@bib80]). We used CB CD34^+^ cells, rather than AB CD34^+^ cells, in order to transduce with the retroviral vectors because of their availability and the efficiency of CD7^+^ progenitor generation from CD34^+^ cells in the OP9DL1 cultures. CB CD34^+^ cells were preactivated for 48 h in Iscove\'s Modified Dulbecco\'s Media (Lonza) supplemented with 10% FBS, 1% nonessential amino acids, 1% glutamine, and 1% Pen/Strep in the presence of 50 ng/ml SCF, 50 ng/ml Flt3L, and 20 ng/ml thrombopoietin (PeproTech). Cells were then transferred on a nontissue culture plate coated with retronectin (TaKaRa) in the presence of supernatant containing the *LIN28B*-expressing or control viral construct, Flt3-liter (0.2 µg/ml), SCF (0.2 µg/ml), and thrombopoietin (40 ng/ml), followed by a centrifugation step for 90 min at 710 *g* at 32°C. After 2 d in culture at 37°C, cells were washed with PBS and seeded in a 6-well culture plate containing OP9DL1 cells as described above. The transduction efficiency was assessed as the percentage of GFP-positive cells by flow cytometry (mean transduction efficiency was 51% for Lin28b and 59% for control).

Flow cytometry and time-of-flight mass cytometry (CyToF) {#s15}
--------------------------------------------------------

The following antibodies were used for flow cytometry: CD3-Pacific Blue (clones SP34-2, UCHT1; BD Biosciences), CD3-V500 (UCHT1; BD Biosciences), CD3-V510 (UCHT1; BD Biosciences), CD3-ECD (UCHT1; Beckman Coulter), TCRγδ-FITC (11F2; BD Biosciences), TCRγδ-PE (11F2; BD Biosciences), TCRγδ-APC (11F2; Miltenyi Biotec), Vδ1-FITC (TS-1; Thermo Scientific), Vδ1-PE (REA173; Miltenyi Biotec), Vδ2-FITC (IMMU 389; Beckman Coulter), Vδ2-Pacific Blue (IMMU 389; Beckman Coulter), Vδ9-PC5 (IMMU 360; Beckman Coulter), CD7-PE-Cy7 (M-T701; BD Biosciences), CD7-V450 (M-T701; BD Biosciences), CD34-PE (AC136; Miltenyi Biotec), CD1a-eFluor450 (HI149; eBioscience), CD1a-PE-Cy7 (HI149; eBioscience), CD1a-PE/Dazzle594 (HI149; BioLegend), CD4-V500 (RPA-T4; BD Biosciences), CD27-PE-Cy7 (M-T271; BD Biosciences), CD27-PE (M-T271; BD Biosciences), Granzyme A-Pacific Blue (CB9; BioLegend), IFNγ-V450 (B27; BD Biosciences), and Tbet-PE (eBio4B10; eBioscience). To assess cell viability, cells were stained with the fixable viability dye Zombie NIR or Zombie red (BioLegend). Cells were washed with PBS (Lonza) supplemented with 0.1% BSA (Sigma-Aldrich) followed by incubation in PBS + 0.1% BSA at 4°C in the dark for 20 min. Cells were then washed again with PBS + 0.1% BSA before fixation in 1% paraformaldehyde (Sigma-Aldrich). Intracellular staining for granzyme A was performed with a Cytofix/Cytoperm kit (BD Biosciences) while the simultaneous detection of IFNγ and Tbet was performed with the Foxp3/transcription factor staining buffer set (eBioscience). For the detection of IFNγ and Tbet, thymocytes were cultured for 4 h in the presence or absence of 10 ng/ml PMA (Sigma-Aldrich) and 2 µM ionomycin calcium salt (Sigma-Aldrich). 5 µg/ml brefeldin A (Sigma-Aldrich) and 2 µM monensin (Sigma-Aldrich) were added 30 min after the beginning of the culture. Cells were run on the CyAn Cyan ADP cytometer (Dako Cytomation) or on the BD LSRFortessa cell analyzer, and data were analyzed using FlowJo software (v9.8.5). Fetal thymocytes were stained as previously described and then analyzed using CyToF ([@bib8]); here, we gated on fetal γδ and αβ thymocytes in order to analyze the expression of IFNγ and Tbet with FlowJo.

TRG, TRD, TRA, and TRB repertoire analysis {#s16}
------------------------------------------

RNA derived from sorted cell populations and from cells harvested from total OP9DL1 co-cultures was isolated following the RNAeasy micro (for sorted cells and cells from total OP9DL1 co-culture when the number of cells was \<10^6^) and mini (cells from total OP9-DL1 culture when the number of cells was \>10^6^) kit protocol (Qiagen). cDNA was generated performing a template-switch anchored RT-PCR. RNA was reverse transcribed via a template-switch cDNA reaction using TRGC (5′-CAA​GAA​GAC​AAA​GGT​ATG​TTC​CAG-3′)- and TRDC (5′-GTAGAATTCCTTCACCAGACAAG-3′)-specific primers in the same reaction tube, a template-switch adaptor (5′-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3′), and the Superscript II RT enzyme (Invitrogen). The TRGC primer binds both TRGC1 and TRGC2. The cDNA was then purified using AMPure XP Beads (Agencourt). Amplification of the TRG and TRD region was achieved using a specific TRGC primer (binding also both TRGC1 and TRGC2 5′-*GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG*AATAGTGGGCTTGGGGGAAACATCTGCAT-3′, adapter in italic), a specific TRDC primer (5′-*GTC​TCG​TGG​GCT​CGG​AGA​TGT​GTA​TAA​GAG​ACA​G*ACG​GAT​GGT​TTG​GTA​TGA​GGC​TGA​CTT​CT-3′, adapter in italic) and a primer complementary to the template-switch adapter (5′-*TCG​TCG​GCA​GCG​TCA​GAT​GTG​TAT​AAG​AGA​CAG*AAG​CAG​TGG​TAT​CAA​CGC​AG-3′, adapter in italic) with the KAPA Real-Time Library Amplification Kit (Kapa Biosystems). Adapters were required for subsequent sequencing reactions. After purification with AMPure XP Beads, an index PCR with Illumina sequencing adapters was performed using the Nextera XT Index Kit. This second PCR product was again purified with AMPure XP beads. HTS of the generated amplicon products containing the CDR3γ or CDR3δ sequences was performed on an Illumina MiSeq platform using the V2 300 kit, with 151 bp at the 3′ end (read 2) and 151 bp at the 5′ end (read 1; at the GIGA Center, University of Liège, Belgium). HTS analysis of TRA and TRB loci was performed as previously described ([@bib78]).

CDR3 sequences were obtained by aligning raw sequencing reads from fastq files (read 1 plus read 2) to reference V, D, and J genes from the GenBank database for TRG or TRD loci using the MiXCR software version 2.1.11 ([@bib3]). Default parameters were used except to assemble TRDD and TRBD gene segments where three instead of five consecutive nucleotides were applied as the assemble parameter. CDR3 sequences were then exported and analyzed using VDJtools software version 1.1.9 using default settings ([@bib73]). Sequences out of frame and containing stop codons were excluded from the analysis. Overlap analysis was performed as the geometric mean of relative overlap frequencies between repertoires (F metrics of VDJtools software). Tree maps were created using the Treemap Package.

Gene expression profile analysis {#s17}
--------------------------------

RNA derived from sorted cell populations was isolated following the RNAeasy micro kit protocol (Qiagen). RNA quality was checked using a Bioanalyzer 2100 (Agilent Technologies). Indexed cDNA libraries were obtained using the Ovation Solo RNA-Seq System (NuGen) following the manufacturer's recommendation. The multiplexed libraries were loaded on a NovaSeq 6000 (Illumina) using an S2 flow cell, and sequences were produced using a 200 Cycle Kit. Paired-end reads were mapped against the human reference genome GRCh38 using STAR software to generate read alignments for each sample. Annotations Homo_sapiens.GRCh38.90.gtf were obtained from [ftp.Ensembl.org](ftp://ftp.Ensembl.org). After transcript assembling, gene level counts were obtained using HTSeq. Differential expression (FT versus PNT γδ thymoctyes, FT versus PNT AB thymocytes, and FL-derived versus AB-derived γδ T cells) was analyzed using EdgeR quasi-likelihood ([@bib67]) running under the Degust platform, where also the Volcano plots (logFoldChange(FC) versus logFalseDiscoveryRate(FDR)) were generated (<http://degust.erc.monash.edu/>). Only genes with a minimum count per million of 1 in each replicate were included. Functional annotation was verified using the functional annotation tool DAVID ([@bib32]). Gene sets of FT versus γδ thymocytes and FL-derived versus AB-derived γδ T cells (logFC \>0.7, FDR \<0.1) were generated for GSEA analysis (Table S1). For the Lin28b versus control comparison, a paired analysis with EdgeR was performed ([@bib67]). Heatmaps were generated using the Mev software: data were log2-transformed and median centered by gene ([@bib31]). GSEA analysis was performed with the default value of 1,000 permutations (permutation type gene set; [@bib77]). Datasets were compared in an unbiased way with GSEA using the gene sets derived from the C7 immunological gene signature from the MSigDB containing 4,872 immunological gene sets ([@bib23]); the following gene sets from this analysis were included: activated human T cells, GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN; activated mouse T cells, GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN; IL15-stimulated human NK cells, GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN; IL15-stimulated mouse NK cells, GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP. The RNA sequencing (RNAseq) data are deposited at the GEO repository, under accession no. [GSE128163](GSE128163).

Statistical analysis {#s18}
--------------------

All statistical analyses were performed using GraphPad Prism 5. Two-tailed Student's *t* test and paired *t* test were used for normally distributed data; Mann Whitney *U* and Wilcoxon matched paired tests were used for nonparametric data. Differences between more than two groups were analyzed using Kruskal--Wallis ANOVA and Dunn's post-tests for nonparametric data. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.

Online supplemental material {#s19}
----------------------------

[Fig. S1](#figS1){ref-type="fig"} shows flow cytometry data on FTs and PNTs. [Fig. S2](#figS2){ref-type="fig"} shows TCR/CDR3 data of FT and PNT γδ thymocytes. [Fig. S3](#figS3){ref-type="fig"} shows CDR3 data on αβ thymocytes. [Fig. S4](#figS4){ref-type="fig"} shows that TRDV10 RNA contains the leader intron introducing a stop codon. [Fig. S5](#figS5){ref-type="fig"} shows TCR/CDR3 and RNAseq data of Lin28b- versus control-transduced CB HSPC-derived γδ T cells. Table S1 shows a list of differentially expressed genes between FT and PNT γδ thymocytes and between FL and AB γδ T cells.
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